The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation
Open accessAbstract
Objectives The purpose of this study was to assess the safety and efficacy of left atrial appendage (LAA) closure in nonvalvular atrial fibrillation (AF) patients ineligible for warfarin therapy.Background The PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that LAA closure with the Watchman device (Boston Scientific, Natick, Massachusetts) was noninferior to warfarin therapy. However, the PROTECT AF trial only included patients who were candidates for warfarin, and even patients randomly assigned to the LAA closure arm received concomitant warfarin for 6 weeks after Watchman implantation.Methods A multicenter, prospective, nonrandomized study was conducted of LAA closure with the Watchman device in 150 patients with nonvalvular AF and CHADS₂ (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and prior stroke or transient ischemic attack) score ≥1, who were considered ineligible for warfarin. The primary efficacy endpoint was the combined events of ischemic stroke, hemorrhagic stroke, systemic embolism, and cardiovascular/unexplained death.Results The mean CHADS₂ score and CHA₂DS₂-VASc (CHADS₂ score plus 2 points for age ≥75 years and 1 point for vascular disease, age 65 to 74 years, or female sex) score were 2.8 ± 1.2 and 4.4 ± 1.7, respectively. History of hemorrhagic/bleeding tendencies (93%) was the most common reason for warfarin ineligibility. Mean duration of follow-up was 14.4 ± 8.6 months. Serious procedure- or device-related safety events occurred in 8.7% of patients (13 of 150 patients). All-cause stroke or systemic embolism occurred in 4 patients (2.3% per year): ischemic stroke in 3 patients (1.7% per year) and hemorrhagic stroke in 1 patient (0.6% per year). This ischemic stroke rate was less than that expected (7.3% per year) based on the CHADS₂ scores of the patient cohort.Conclusions LAA closure with the Watchman device can be safely performed without a warfarin transition, and is a reasonable alternative to consider for patients at high risk for stroke but with contraindications to systemic oral anticoagulation. (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology [ASAP]; NCT00851578).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“occlusion may also reduce stroke risk in patients with contraindications to OAC. 454,455”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [454]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,929
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · cited 1×
“In the AVERROES (Apixaban Versus Acetylsalicylic Acid to Prevent Strokes in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment) study, warfarin-ineligible patients were randomly allocated to either aspirin or the factor Xa inhibitor, apixaban (21).”
MethodHolmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., Mullin, C. M., & Sick, P. B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61343-x · Cited by 2,242
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · cited 2×
“Clopidogrel has been reported to reduce ischemic stroke by 32% (13).”
BackgroundMethodMant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181fa3cf4 · Cited by 1,338
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 726
Current Therapeutic Approach to Atrial Fibrillation in Patients with Congenital Hemophilia
Bădescu, M. C., Bădulescu, O. V., Butnariu, L. I., Floria, M., Ciocoiu, M., Costache, I. I., Popescu, D., Bratoiu, I., Buliga-Finiș, O. N., & Rezuș, C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040519 · Cited by 12
Tung, M., Ramkumar, S., Cameron, J. D., Pang, B., Nerlekar, N., Kotschet, E., & Alison, J. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.09.009 · Cited by 12
Myrda, K., Streb, W., Wojakowski, W., Piegza, J., Mitręga, K., Smolka, G. A., Nowak, J., Podolecki, T., Gasiewska-Żurek, E., Nowowiejska-Wiewióra, A., et al. (2022) · Kardiologia Polska · doi:10.33963/kp.a2022.0047 · Cited by 11
Beneki, E., Dimitriadis, K. S., Theofilis, P., Pyrpyris, N., Iliakis, P., Kalompatsou, A., Kostakis, P. G., Koukos, M., Σουλαϊδόπουλος, Σ., Τζίμας, Γ., et al. (2025) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-025-03330-z · Cited by 11
Kretzler, L., Mues, C. A., Wunderlich, C., Langbein, A., Spitzer, S. G., Gerk, U., Schellong, S., Ketteler, T., Neuser, H., Schwefer, M., et al. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02708-4 · Cited by 11
Farwati, M., Amin, M., Isogai, T., Saad, A. M., Abushouk, A. I., Krishnaswamy, A., Wazni, O. M., & Kapadia, S. R. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024574 · Cited by 11
Antithrombotic Regimen After Percutaneous Left Atrial Appendage Closure ― A Real-World Study ―
Ryuzaki, S., Kondo, Y., Nakano, M., Nakano, M., Kajiyama, T., Ito, R., Kitagawa, M., Sugawara, M., Chiba, T., Yoshino, Y., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0687 · Cited by 11
Catheter based left atrial appendage closure in-hospital outcomes in Germany from 2016 to 2020
Maier, A., Kaier, K., Heidt, T., Westermann, D., Mühlen, C. V. Z., & Grundmann, S. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02299-w · Cited by 11
Definition and anatomical description of the left atrial appendage neck
Batko, J., Jakiel, R., Krawczyk‐Ożóg, A., Litwinowicz, R. A., Hołda, J., Bartuś, S., Bartuś, K., Holda, M. K., & Konieczyńska, M. (2023) · Clinical Anatomy · doi:10.1002/ca.24125 · Cited by 11
Single antiplatelet therapy following Amplatzer left atrial appendage occlusion
Kramer, A. D., Korsholm, K., & Nielsen‐Kudsk, J. E. (2024) · EuroIntervention · doi:10.4244/eij-d-23-00684 · Cited by 11
Khattab, A. A., Gloekler, S., Sprecher, B., Shakir, S., Guérios, Ê. E., Stortecky, S., O'Sullivan, C. J., Nietlispach, F., Moschovitis, A., Pilgrim, T., et al. (2014) · Open Heart · doi:10.1136/openhrt-2013-000014 · Cited by 11
Transesophageal Echocardiography in Atrial Fibrillation
Yingchoncharoen, T., Jha, S. K., Burchill, L. J., & Klein, A. L. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.11.006 · Cited by 11
Noelck, N. J., Papak, J., Freeman, M., Paynter, R. A., Low, A., Motu’apuaka, M. L., Kondo, K. K., & Kansagara, D. L. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002539 · Cited by 11
Imaging for percutaneous left atrial appendage closure
Prakash, R., & Saw, J. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26828 · Cited by 11
Run With the Hare and Hunt With the Hounds
O'Hara, C., O’Hara, G. E., Jacques, F., Champagne, J., Lemyre, M., Charbonneau, L., O’Connor, K., Bernier, M., Beaudoin, J., Rodés‐Cabau, J., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.09.041 · Cited by 11
Left atrial appendage occlusion: A better alternative to anticoagulation?
Akın, İ., & Nienaber, C. A. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i2.139 · Cited by 11
Merella, P., Lorenzoni, G., Marziliano, N., Berne, P., Viola, G., Pischedda, P., & Casu, G. (2018) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000735 · Cited by 11
Melillo, E., Carbone, A., Rago, A., Papa, A. A., Onofrio, A. D., Nigro, G., Golino, P., & Russo, V. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000786 · Cited by 11
Percutaneous left atrial appendage occlusion
Mohammed, M., Ranka, S., & Reddy, M. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000818 · Cited by 11
Gala, A. R. P. B. E., Pope, M., Monteiro, C., Leo, M., Dawkins, S., Newton, J. D., & Betts, T. R. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.06.1170 · Cited by 11
Jackson, L. R., JACKSON, K. P., & Thomas, K. L. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.06.006 · Cited by 11
Continisio, S., Montonati, C., Angelini, F., Bocchino, P. P., Carbonaro, C., Giacobbe, F., Dusi, V., FILIPPO, O. D., Ielasi, A., Giannino, G., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14209 · Cited by 10
Huang, W., Zhang, Y., He, L., Su, X., Yang, X., & Guo, Z.-X. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.199832 · Cited by 10
LIN, A. C., & Knight, B. P. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.009 · Cited by 10
Left atrial appendage occlusion device infection: Take it or leave it?
Madanat, L., Bloomingdale, R. J., Shah, K. B., Khalife, A., Haines, D. E., & Mehta, N. K. (2021) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2021.08.006 · Cited by 10
Magdi, M., Renjithal, S. L. M., Mubasher, M., Mostafa, M. R., Lathwal, Y., Mukuntharaj, P., Mohamed, S., Alweis, R. L., Tan, B. E., & Baibhav, B. (2021) · PubMed Central · Cited by 10
Left atrial appendage exclusion in atrial fibrillation
Rozen, G., Margolis, G., Marai, I., Roguin, A., Rahamim, E., Planer, D., Heist, E. K., Amir, O., Tahiroglu, I., Ruskin, J. N., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.949732 · Cited by 10
Ma, Y., Guo, L., Li, J., Liu, H., Xu, J., Du, H., Wang, Y., Li, H., & Fu, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010160 · Cited by 10
Kebernik, J., Jose, J., Abdel‐Wahab, M., Stöcker, B., Geist, V., & Richardt, G. (2015) · Cardiology and Therapy · doi:10.1007/s40119-015-0053-z · Cited by 10
Strategies to Incorporate Left Atrial Appendage Occlusion Into Clinical Practice
Alli, O. O., Asirvatham, S. J., & Holmes, D. R. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.564 · Cited by 10
Left Atrial Appendage Closure for Stroke Prevention
Iskandar, S., Vacek, J. L., Lavu, M., & Lakkireddy, D. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2015.12.009 · Cited by 10
Turagam, M. K., Parikh, V. K., Afzal, M. R., Gopinathannair, R., Lavu, M., Kanmanthareddy, A., Pillarisetti, J., Reddy, M., Atkins, D., Bommana, S., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13254 · Cited by 10
Multiple Thromboembolic Events from a Left Atrial Appendage Occlusion Device
Prosperi‐Porta, G., Schnell, G., Colbert, J. D., Franko, A. D., Wilton, S. B., & Kuriachan, V. P. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.017 · Cited by 10
Indication, Patient Selection, and Referral Pathways for Left Atrial Appendage Closure
Dar, T. A., Turagam, M. K., Yarlagadda, B., Tantary, M., Sheldon, S. H., & Lakkireddy, D. (2018) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2017.12.003 · Cited by 10
Current State of Left Atrial Appendage Closure
Kosturakis, R., & Price, M. J. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0981-z · Cited by 10
Chen, Y., Zhang, Y., Qu, L., Huang, W., Su, X., & Chen, Y. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02408-4 · Cited by 10
Left Atrial Appendage Closure Device With Delivery System: A Health Technology Assessment.
(2017) · PubMed Central · Cited by 10
Zhou, X., Chen, Q., Fang, L., Wang, L., Chen, Y., Liang, D., Huang, W., & Xiao, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030847 · Cited by 10
Antithrombotic therapy after left atrial appendage closure
Schmidt, B., & Chun, K. R. J. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.988612 · Cited by 10
Miller, D. J., Shah, K. B., Modi, S., Mahajan, A., Zahoor, S., & Affan, M. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0400-y · Cited by 9
First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure
Seeger, J., Birkemeyer, R., Rottbauer, W., & Wöhrle, J. (2017) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2017.04.018 · Cited by 10
Akca, F., Verberkmoes, N. J., Verstraeten, S. E., van Laar, C., van Putte, B. P., & van Straten, A. H. M. (2017) · Netherlands Heart Journal · doi:10.1007/s12471-017-0987-y · Cited by 10
The WATCHMAN Device Review: A new era for stroke prophylaxis
Khan, S., Naz, H., Khan, M. S. Q., Ullah, A., Satti, D. I., Malik, J., & Mehmoodi, A. (2023) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.55729/2000-9666.1183 · Cited by 9
Yasmin, F., Ali, E., Moeed, A., Zaidi, S. F., Umar, M., & Virwani, V. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295804 · Cited by 9
Muiños, P. J. A., López‐Tejero, S., Guillén, P. L. C., Mon-Noboa, M., Ruiz-Nodar, J. M., Lalaguna, L. A., Rivero, F., Cordoba-Soriano, J. G., Amat-Santos, I. J., Caneiro‐Queija, B., et al. (2024) · EuroIntervention · doi:10.4244/eij-d-24-00116 · Cited by 9
Thiankhaw, K., Best, J. G., Srivastava, S., Prachee, I., Agarwal, S., Tan, S., Calvert, P. A., Chughtai, A., Ang, R., Segal, O. R., et al. (2024) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2024-334718 · Cited by 9
Mavridis, T., Barakakis, P. A., Chlorogiannis, D., & Charidimou, A. (2025) · International Journal of Stroke · doi:10.1177/17474930251360076 · Cited by 9
Left Atrial Appendage Closure: A Narrative Review
Nagasaka, T., & Nakamura, M. (2023) · Cardiology and Therapy · doi:10.1007/s40119-023-00337-2 · Cited by 9
Fastner, C., Behnes, M., Sartorius, B., Wenke, A., El‐Battrawy, I., Ansari, U., Gill, I. S., Borggrefe, M. M., & Akın, İ. (2017) · Clinical Cardiology · doi:10.1002/clc.22699 · Cited by 9
Device related thrombus after left atrial appendage closure: State of the art
Yu, J., Bai, Y., & Jiang, L. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14122 · Cited by 9
Current practice and future prospects in left atrial appendage occlusion
Narasimhan, B., Aedma, S. K., Bhatia, K., Garg, J., Kanuri, S. H., Turagam, M. K., & Lakkireddy, D. (2021) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14284 · Cited by 9
Li, X., Zhang, X., Jin, Q., Li, Y., Zhou, D., Lv, Q., & Ge, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723905 · Cited by 9
Prevention and Management of Complications of Left Atrial Appendage Closure Devices
Price, M. J. (2014) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2013.12.001 · Cited by 9
Left atrial appendage occlusion
Nietlispach, F., Moarof, I., Taramasso, M., Maisano, F., & Meier, B. (2017) · EuroIntervention · doi:10.4244/eij-d-17-00412 · Cited by 11
Waks, J. W., & Manning, W. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.593 · Cited by 9
The evolution of left atrial appendage occlusion: EWOLUTION and the WATCHMAN in practice
Masoudi, F. A. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw041 · Cited by 9
What Lies Beneath Left Atrial Appendage Occlusion
Meier, B. (2018) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.118.006360 · Cited by 9
Left atrial appendage occlusion for atrial fibrillation and bleeding diathesis
Kailey, B. S., Koa‐Wing, M., Sutaria, N., Mott, T., Sohaib, A., Qureshi, N. A., Shi, C., Padam, P., Howard, J., & Kanagaratnam, P. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16105 · Cited by 8
Left Atrial Appendage Devices for Stroke Prevention in Atrial Fibrillation
HUSSAIN, S. K., Malhotra, R., & Dimarco, J. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9565-5 · Cited by 8
Stroke Prevention in Atrial Fibrillation
Gao, X., & PASSMAN, R. S. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01787-1 · Cited by 8
Virtual reality utilization for left atrial appendage occluder device size prediction
Tejman‐Yarden, S., Freidin, D., Nagar, N., Parmet, Y., Abed, M., Vazhgovsky, O., Yogev, D., Ganchrow, D., Mazor-Drey, E., Chatterji, S., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14790 · Cited by 8
Stroke prevention and intracranial hemorrhage risk in atrial fibrillation management: A mini review
Roychoudhury, R., Shuangtao, M., & Qian, C. (2023) · Brain Circulation · doi:10.4103/bc.bc_22_23 · Cited by 8
LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders
Bergmann, M. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.03.006 · Cited by 8
Lifetech LAmbre: A New Promising and Novel Device in the Interventional Stroke Prevention
Schnupp, S., Ajmi, I., Brachmann, J., & Mahnkopf, C. (2019) · Future Cardiology · doi:10.2217/fca-2019-0040 · Cited by 8
Zweiker, D., Sieghartsleitner, R., Fiedler, L., Tóth, G. G., Luha, O., Stix, G., Gabriel, H., Vock, P., Lileg, B., Strouhal, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103274 · Cited by 8
Gökçal, E., Horn, M. J., & Gurol, M. E. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819814-8.00021-4 · Cited by 8
Safety of left atrial appendage closure in heart failure patients
Das, S., Ros, M. L., Wu, L., Mehta, D., & Suri, R. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15682 · Cited by 8
Impact and predictors of device-related thrombus after percutaneous left atrial appendage closure
Branca, L., Tomasoni, D., Cimino, G., Cersosimo, A., Lombardi, C., Chizzola, G., Metra, M., & Adamo, M. (2022) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001394 · Cited by 8
When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies
Merella, P., Casu, G., Chessa, P., Atzori, E., Bandino, S., & Deiana, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247704 · Cited by 9
Bode, W. D., Patel, N. A., & Gehi, A. K. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-9988-1 · Cited by 8
Non-Pharmacological Therapy for Atrial Fibrillation: Managing the Left Atrial Appendage
Luis, S. A., Roper, D., Incani, A., Poon, K., Haqqani, H. M., & Walters, D. (2012) · Cardiology Research and Practice · doi:10.1155/2012/304626 · Cited by 8
Fastner, C., Lehmann, R., Behnes, M., Sartorius, B., Borggrefe, M. M., & Akın, İ. (2016) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2016.01.006 · Cited by 8
Left Atrial Appendage Exclusion for Atrial Fibrillation
Syed, F. F., DeSimone, C. V., Friedman, P. A., & Asirvatham, S. J. (2016) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.022 · Cited by 8
Wei, Z.-H., Zhang, X.-L., Wu, H., Xie, J., Dai, Q., Wang, L., & Xu, B. (2016) · Medicine · doi:10.1097/md.0000000000004382 · Cited by 14
Tjoe, B., Nguyen, H., Mandava, S., Quintos, J., Li, J., Yim, S., Shafer, C. D., Thompson, C. D., Shenoda, M., Cogert, G. A., et al. (2021) · Structural Heart · doi:10.1080/24748706.2021.1890286 · Cited by 8
Mazzone, P., D’Angelo, G., Regazzoli, D., Molon, G., Senatore, G., Saccà, S., Canali, G., Amellone, C., Turri, R., & Bella, P. E. D. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0351-1 · Cited by 8
Gao, C., Su, F., Liu, J., Zhang, T., Ning, Z., Yang, B., Chu, H., He, B., Zhang, J., Zhou, L., et al. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.07.013 · Cited by 7
Antiplatelet Therapy in Heart Disease
Özyüncü, N. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm36522 · Cited by 9
Atrial Fibrillation in Kidney Failure: Challenges in Risk Assessment and Anticoagulation Management
Law, M. M., Tan, S., Wong, M. C. G., & Toussaint, N. D. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100690 · Cited by 7
Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation
Fender, E. A., Kiani, J. G., & Holmes, D. R. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0616-z · Cited by 7
Fanari, Z., Goel, S. S., & Goldstein, J. A. (2017) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2017.05.019 · Cited by 7
Horie, K., Matsumoto, T., Mizutani, Y., Tada, N., Osai, N., Isawa, T., Taguri, M., Kato, S., Honda, T., Ootomo, T., et al. (2019) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-019-00589-7 · Cited by 8
Wintgens, L. I. S., Vorselaars, V. M. M., Klaver, M. N., Swaans, M. J., Alipour, A., Rensing, B. J. W. M., Post, M. C., & Boersma, L. V. A. (2019) · Netherlands Heart Journal · doi:10.1007/s12471-019-1295-5 · Cited by 7
Evidence and uncertainties in the management of atrial fibrillation in the elderly
Alboni, P., Bo, M., Fumagalli, S., Vetta, F., Isaia, G., Brunetti, E., Baldasseroni, S., Boccanelli, A., Desideri, G., Marchionni, N., et al. (2022) · Minerva Medica · doi:10.23736/s0026-4806.21.07525-x · Cited by 7
Yan, T., Zhu, S., Zhu, M., Zhu, K., Dong, L., Wang, C., & Guo, C. (2021) · International Heart Journal · doi:10.1536/ihj.20-765 · Cited by 7
Left atrial appendage closure: First in man with the 4th generation watchman device
Ledwoch, J., Franke, J., Gonzaga, M., Bertog, S. C., Braut, A., Hofmann, I., Vaškelytė, L., Gafoor, S. A., Reddy, V. Y., & Sievert, H. (2015) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26238 · Cited by 7
Left Atrial Appendage Closure Devices For Stroke Prevention
Kapur, S., & Mansour, M. (2014) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2011.3.1.25 · Cited by 7
Five years of keeping a watch on the left atrial appendage—how has the WATCHMAN fared?
Jazayeri, M., Vuddanda, V. L. K., Parikh, V. K., Lavu, M., Atkins, D., Reddy, Y. M., Nath, J., & Lakkireddy, D. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.57 · Cited by 7
Left Atrial Appendage Occlusion: What Are the Options and Where is the Evidence?
Chava, R., Turagam, M. K., & Lakkireddy, D. (2018) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2018.090402 · Cited by 7
Reinsch, N., Ruprecht, U., Buchholz, J., Edel, C., Kälsch, H., & Neven, K. G. E. J. (2018) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000663 · Cited by 7
Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients
Zhai, Z. (2019) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2019.75435 · Cited by 7
Ajmal, M., Hutchinson, M. D., Lee, K. S. S., & Indik, J. H. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-00958-4 · Cited by 7
Matos, A. J. P., Swaans, M. J., Rensing, B. J. W. M., Heijmen, R. H., Mast, E. G., Boersma, L. V. A., & Post, M. C. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.01.177 · Cited by 7
Bertrand, P. B., Habran, M., Kenis, K., Lecomte, J., Moonen, L., Stroobants, D., & Benit, E. (2018) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2018.1455946 · Cited by 7
Short- and long-term outcomes of percutaneous left atrial appendage occlusion in cancer patients
Tinoco, M. G., Echarte‐Morales, J., Guerreiro, C., Gil, E. M. A., Caneiro‐Queija, B., Barreiro‐Pérez, M., González-Ferreiro, R., Fernández, S., Sáez, A. O., Díaz, V. A. J., et al. (2024) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2024.101585 · Cited by 6
Chen, M., Wang, Q., Sun, J., Zhang, P., Li, W., Mo, B., Chen, T.-Z., Tang, X., & Li, Y. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044695 · Cited by 6
Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
Chinese Society of Cardiology, C. M. A., & Heart Rhythm Committee of Chinese Society of Biomedical Engineering (2024) · Cardiology Discovery · doi:10.1097/cd9.0000000000000123 · Cited by 7
Left Atrial Appendage Closure for Stroke Prevention
Syed, F. F., & Friedman, P. A. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.12.002 · Cited by 6
Transcatheter Aortic Valve Replacement and Left Atrial Appendage Occlusion – A Stitch in Time?
Gafoor, S. A. (2011) · Interventional Cardiology Reviews Research Resources · doi:10.15420/articles/transcatheter-aortic-valve-replacement-and-left-atrial-appendage-occlusion-stitch-time · Cited by 6
Anatomic Considerations for Epicardial and Endocardial Left Atrial Appendage Closure
Voskoboinik, A., & Lee, R. J. (2019) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.11.001 · Cited by 6
Metadata
- Authors
- Reddy, V. Y., Möbius-Winkler, S., Miller, M. A., Neuzil, P., Schuler, G., Wiebe, J., Sick, P., & Sievert, H.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Leipzig Heart Institute (DE)
- Cardiovascular Center Frankfurt (DE)
- Krankenhaus Barmherzige Brüder (DE)
- Corresponding author
- Reddy, Vivek Y.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 61
- Issue
- 25
- Pages
- 2551-2556
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2115996784
- Cited by
- 727
- References
- 31
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 46 · 2023: 51 · 2022: 43 · 2021: 57 · 2020: 48 · 2019: 59 · 2018: 61 · 2017: 72 · 2016: 83 · 2015: 75 · 2014: 59 · 2013: 17
- FWCI
- 52.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Boston Scientific
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- left atrial appendage closure, Watchman device, non-valvular atrial fibrillation, stroke prevention, systemic embolism, CHADS2 score, CHA2DS2-VASc score, bleeding risk, procedural safety, ischemic stroke, hemorrhagic stroke, anticoagulation alternatives
- MeSH terms
- Contraindications, Clopidogrel, Administration, Oral, Aged, Aged, 80 and over, Anticoagulants, Feasibility Studies, Female, Follow-Up Studies, Humans, Male, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Atrial Appendage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
